Tirosint

IBSA Pharma Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 25, 2026
Approval ID: 7a7ade79-0165-4e31-b84e-667416c00c7e
Products: 15 registered
Version: 13

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use TIROSINT® safely and effectively. See full prescribing information for TIROSINT. TIROSINT® (levothyroxine sodium) capsules, for oral use Initial U.S. Approval: 2000

Quick Stats

Total Products15

Labelers2

Label Sections52

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.